Read" />

Late-stage RSV vaccine trials show ‘exciting promise,’ some scientists say – CNN

A Pfizer vaccine to protect older adults and infants from respiratory syncytial virus (RSV) infection has shown what some scientists are calling exciting promise in late-stage trials.
In one company Read More

Leave a Reply

Your email address will not be published. Required fields are marked *